Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $17.70 Analyst target: $55.00 Upside: 210.73%
EUDA Health Holdings Limited is a forward-looking biopharmaceutical company focused on innovating treatments for rare diseases and addressing unmet medical needs. Leveraging advanced technologies, the firm is developing a robust clinical pipeline with a particular emphasis on supportive care and immune modulation. EUDA's strong commitment to research and development positions it favorably in the healthcare landscape, aiming to enhance patient outcomes and expand access to crucial therapies.
See the full interactive analysis & chart →Informational only — not investment advice.